Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood

American Journal of Veterinary Research

Volumn 63, Issue 1, 2002, Pages 91-94

  Streppa, Heather K ^a   Jones, Chris J ^a   Budsberg, Steven C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARPROFEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ETODOLAC; HEPARIN; IBUPROFEN; KETOPROFEN; LIPOPOLYSACCHARIDE; MECLOFENAMIC ACID; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ARTICLE; BLOOD; BLOOD CLOT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARINIZATION; IC 50; IN VITRO STUDY; MALE; NONHUMAN;

ANIMALS; CROSS-OVER STUDIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THROMBOXANE B2;

ANIMALIA; CANIS FAMILIARIS;

EID: 0036383457     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/AJVR.2002.63.91     Document Type: Article

References (25)

1. Amin AR, Vyas P, Attur M, et al. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci U S A 1995;92:7926-7930.
2. Boothe DM. Anti-inflammatory drugs. In: Boothe DM, ed. Small animal clinical pharmacology and therapeutics. Philadelphia: WI3 Saunders Co, 2001;281-297.
3. Furst DE. Pharmacology and efficacy of cyclooxygenase (COX) inhibitors. Am J Med 1999;107:18S-26S.
4. Hersh EV, Moore PA, Ross GL. Over-the-counter analgesics and antipyrretics: a critical assessment. Clin Ther 2000;22:500-548.
5. Johnston SA, Fox SM. Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. J Am Vet Med Assoc 1997;210:1486-1492.
6. Kore AM. Toxicology of nonsteroidal anti-inflammatory drugs. Vet Clin North Am Small Anim Pract 1990;20:419-430.
7. Lees P, May SA, McKellar QA. Pharmacology and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat. 1. General pharmacology. J Small Anim Pract 1991;32:183-193.
8. McKellar QA, May SA, Lees P. Pharmacology and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat. 2. Individual agents. J Small Anim Pract 1991;32:225-235.
9. Rainsford KD. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med 1999;107:27S-36S.
10. Taylor PM. Newer analgesics- nonsteroid anti-inflammatory drugs, opioids, and combinations. Vet Clin North Am Small Anim Pract 1999;29:719-735.
11. Wallace JL. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med 1999;107:11S-16S.
12. Jones CJ, Budsberg SC. Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats. J Am Vet Med Assoc 2000;217:721-729.
13. Ricketts AP, Lundy KM, Seibel SB. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am J Vet Res 1998;59: 1441-1446.
14. Kay-Mugford PA, Benn SJ, LaMarre J, et al. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res 2000;61:802-810.
15. Kay-Mugford PA, Benn SJ, LaMarre J, et al. Cyclooxygenase expression in canine platelets and Madin-Darby canine kidney cells. Am J Vet Res 2000;61:1512-1516.
16. Brideau C, Kargman S, Liu S, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 1996;45:68-74.
17. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:413-421.
18. Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999;96:7563-7568.
19. Engelhardt G, Bogel R, Schnitzer C, et al. Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings. Biochem Pharmacol 1996;51:21-28.
20. Laine L, Sloane R, Ferretti M, et al. A randomized, double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc 1995;42:428-433.
21. Reimer ME, Johnston SA, Leib MS, et al. The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs. J Vet Intern Med 1999;13:472-477.
22. Budsberg SC, Johnston SA, Schwarz PD, et al. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. J Am Vet Med Assoc 1999;214:206-210.
23. Cross AR, Budsberg SC, Keefe TJ. Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-incluced synovitis model in dogs. Am J Vet Res 1997;58:626-631.
24. Grisneaux E, Pibarot P, Dupuis J, et al. Comparison of ketoprofen and carprofen administered prior to orthopedic surgery for control of postoperative pain in dogs. J Am Vet Med Asoc 1999;215:1105-1110.
25. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis indogs. J Am Vet Med Assoc 1995;206:807-811.